A Potential Role for Interleukin-8 in the Metastatic Phenotype of Breast Carcinoma Cells
- 28 February 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 158 (2) , 639-646
- https://doi.org/10.1016/s0002-9440(10)64005-9
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Defense (R01-CA 29995)
- National Institutes of Health (R01-CA 29995)
This publication has 25 references indexed in Scilit:
- Oct-1 and CCAAT/Enhancer-binding Protein (C/EBP) Bind to Overlapping Elements within the Interleukin-8 PromoterJournal of Biological Chemistry, 1997
- Angiogenesis: new aspects relating to its initiation and controlAPMIS, 1997
- Interferon-β Prevents the Upregulation of Interleukin-8 Expression in Human Melanoma CellsJournal of Interferon & Cytokine Research, 1996
- Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.Journal of Clinical Investigation, 1996
- Differential Endothelial Migration and Proliferation to Basic Fibroblast Growth Factor and Vascular Endothelial Growth FactorGrowth Factors, 1996
- Interleukin-8 as a Macrophage-Derived Mediator of AngiogenesisScience, 1992
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989
- Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1988
- Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.Proceedings of the National Academy of Sciences, 1987
- The Biology of Cancer Invasion and MetastasisPublished by Elsevier ,1978